Boston Scientific CorporationBSXNYSE
Loading
Year-over-year total asset growth rate
3Y CAGR
+11.5%/yr
vs -42.8%/yr prior
Acceleration
+54.3pp
Accelerating
Percentile
P64
Within normal range
vs 3Y Ago
1.4x
Solid growth
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.26% |
| Q3 2025 | 2.76% |
| Q2 2025 | 3.54% |
| Q1 2025 | 1.89% |
| Q4 2024 | 3.46% |
| Q3 2024 | 2.61% |
| Q2 2024 | 1.20% |
| Q1 2024 | 4.36% |
| Q4 2023 | 3.21% |
| Q3 2023 | 1.32% |
| Q2 2023 | 2.16% |
| Q1 2023 | 1.30% |
| Q4 2022 | 1.63% |
| Q3 2022 | -0.75% |
| Q2 2022 | -0.45% |
| Q1 2022 | 0.33% |
| Q4 2021 | 1.11% |
| Q3 2021 | 2.27% |
| Q2 2021 | 0.87% |
| Q1 2021 | 0.40% |
| Q4 2020 | -0.22% |
| Q3 2020 | 0.07% |
| Q2 2020 | 2.36% |
| Q1 2020 | -1.48% |
| Q4 2019 | 14.24% |
| Q3 2019 | 10.07% |
| Q2 2019 | 2.13% |
| Q1 2019 | 13.35% |
| Q4 2018 | 3.04% |
| Q3 2018 | 3.89% |
| Q2 2018 | 2.16% |
| Q1 2018 | 0.84% |
| Q4 2017 | 2.17% |
| Q3 2017 | 1.38% |
| Q2 2017 | 2.45% |
| Q1 2017 | -0.85% |
| Q4 2016 | 2.25% |
| Q3 2016 | -0.79% |
| Q2 2016 | 0.68% |
| Q1 2016 | -2.29% |